Analyst firms · BofA Securities · SBRA
BofA Securities SBRA price target and rating history
Sabra Health Care REIT Inc. (SBRA) · Real Estate
BofA Securities rates Sabra Health Care REIT Inc. (SBRA) Buy with a $16 price target, as of its latest action on Oct 10, 2023. It has published 4 rating actions on SBRA since March 2022, including 3 upgrades and 1 downgrade. Across 4 firms with a SBRA price target in the last 12 months, the median target is $20.50.
- Current rating
- Buy
- Price target
- $16
- Median target, all firms
- $20.50
- Actions on SBRA
- 4
BofA Securities price target on SBRA
Every BofA Securities rating on SBRA
- Oct 10, 2023
- Aug 11, 2023
- Nov 14, 2022
- Mar 11, 2022
How other firms rate SBRA
Each firm's latest rating and stated target in the last 12 months.
| Firm | Rating | Price target | Date |
|---|---|---|---|
| Huntington | Outperform | $23 | Sep 10, 2026 |
| Raymond James | Mkt Perform | Aug 6, 2026 | |
| Truist Securities | Hold | Jul 8, 2026 | |
| Barclays | Overweight | $21 | Jul 7, 2026 |
| Citigroup | Neutral | $19 | Jun 23, 2026 |
| UBS | Neutral | $20 | Nov 18, 2025 |
Questions about BofA Securities and SBRA
- What is BofA Securities's price target for SBRA?
- BofA Securities's latest stated price target for Sabra Health Care REIT Inc. (SBRA) is $16, from its action on Oct 10, 2023.
- What is BofA Securities's rating on SBRA?
- BofA Securities rates SBRA Buy, a bullish rating, as of Oct 10, 2023.
- When did BofA Securities last change its view on SBRA?
- On Oct 10, 2023, BofA Securities upgrades to Buy from Neutral, price target $14 to $16.
- How does BofA Securities's SBRA target compare with other analysts?
- Across 4 firms with a SBRA price target in the last 12 months, the median target is $20.50.
More SBRA rating histories
All BofA Securities ratingsSBRA news and filingsEvery analyst firm
From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.